Stay updated with breaking news from David Erlinge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
<p><strong>Half of all patients discharged from hospital after a heart attack are treated with beta-blockers unnecessarily. This is according to a new study published in the New England Journal of Medicine. "I am convinced that this will influence future practice", says Tomas Jernberg, Professor at Karolinska Institutet and lead researcher of the study.</strong></p>
Half of all patients discharged from hospital after a heart attack are treated with beta-blockers unnecessarily. This is according to a new study
Primary endpoint, six-month clinical and imaging data from clinical trial of DESyne BDS Plus stent system evaluating safety and efficacy of localized delivery of anticoagulants and an anti-proliferative agent designed to reduce the implant thrombotic risk
Largest randomized trial of DynamX Bioadaptor to date with 2,400 patients enrolled, covering real-world population
E-Mail Researchers at Lund University in Sweden can now show that a new examination method identifies high-risk plaques in the blood vessels surrounding the heart, that cannot be seen solely with traditional angiograms. This type of plaque, rich in fat, could potentially cause recurring heart attacks in patients with heart disease. The study is published in the The Lancet. "We have been working on this study for ten years. This creates a unique opportunity to treat plaques before they cause a heart attack", says David Erlinge, professor of cardiology at Lund University and Consultant in In...